Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?

Tzung Hai Yen, Chiu Ching Huang, Hsin Hung Lin, Jeng Yi Huang, Ya Chun Tian, Chih Wei Yang, Mai Szu Wu, Ji Tseng Fang, Chun Chen Yu, Yang Jen Chiang, Sheng Hsieh Chu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background. Hepatitis B virus (HBV) is endemic in Taiwan. Transplantation followed by long-term immunosuppressive medications may precipitate HBV reactivation. Interference of hepatitis C virus (HCV) with HBV gene expression and replication has been confirmed in many studies involving non-transplant populations. This study investigates the incidence of HBV reactivation following renal transplantation and compares the clinical outcome, especially the liver outcome, of patients with or without HCV co-infection. Methods. Fifty-one of 512 renal transplant recipients were positive for hepatitis B surface antigen before surgery, and were followed for 81.6±7.5 (4-120) months. Seventeen of 51 patients acquired HCV before transplantation and six patients acquired HCV after renal transplantation. Results. At the end of this assessment, we had 28 patients who suffered HBV reactivation and another 23 patients who suffered no HBV reactivation. Initially, we found a significant difference of HCV carriage (P

Original languageEnglish
Pages (from-to)1046-1052
Number of pages7
JournalNephrology Dialysis Transplantation
Volume21
Issue number4
DOIs
Publication statusPublished - Apr 2006
Externally publishedYes

Fingerprint

Hepatitis B virus
Hepacivirus
Kidney Transplantation
Transplantation
Virus Diseases
Immunosuppressive Agents
Hepatitis B Surface Antigens
Coinfection
Taiwan
Cohort Studies
Kidney
Gene Expression
Liver
Population

Keywords

  • Co-infection
  • HBV
  • HCV
  • Reactivation
  • Renal transplantation

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Yen, T. H., Huang, C. C., Lin, H. H., Huang, J. Y., Tian, Y. C., Yang, C. W., ... Chu, S. H. (2006). Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation? Nephrology Dialysis Transplantation, 21(4), 1046-1052. https://doi.org/10.1093/ndt/gfk023

Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation? / Yen, Tzung Hai; Huang, Chiu Ching; Lin, Hsin Hung; Huang, Jeng Yi; Tian, Ya Chun; Yang, Chih Wei; Wu, Mai Szu; Fang, Ji Tseng; Yu, Chun Chen; Chiang, Yang Jen; Chu, Sheng Hsieh.

In: Nephrology Dialysis Transplantation, Vol. 21, No. 4, 04.2006, p. 1046-1052.

Research output: Contribution to journalArticle

Yen, TH, Huang, CC, Lin, HH, Huang, JY, Tian, YC, Yang, CW, Wu, MS, Fang, JT, Yu, CC, Chiang, YJ & Chu, SH 2006, 'Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?', Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 1046-1052. https://doi.org/10.1093/ndt/gfk023
Yen, Tzung Hai ; Huang, Chiu Ching ; Lin, Hsin Hung ; Huang, Jeng Yi ; Tian, Ya Chun ; Yang, Chih Wei ; Wu, Mai Szu ; Fang, Ji Tseng ; Yu, Chun Chen ; Chiang, Yang Jen ; Chu, Sheng Hsieh. / Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?. In: Nephrology Dialysis Transplantation. 2006 ; Vol. 21, No. 4. pp. 1046-1052.
@article{ffebb9ad861a47c18625f21259964648,
title = "Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?",
abstract = "Background. Hepatitis B virus (HBV) is endemic in Taiwan. Transplantation followed by long-term immunosuppressive medications may precipitate HBV reactivation. Interference of hepatitis C virus (HCV) with HBV gene expression and replication has been confirmed in many studies involving non-transplant populations. This study investigates the incidence of HBV reactivation following renal transplantation and compares the clinical outcome, especially the liver outcome, of patients with or without HCV co-infection. Methods. Fifty-one of 512 renal transplant recipients were positive for hepatitis B surface antigen before surgery, and were followed for 81.6±7.5 (4-120) months. Seventeen of 51 patients acquired HCV before transplantation and six patients acquired HCV after renal transplantation. Results. At the end of this assessment, we had 28 patients who suffered HBV reactivation and another 23 patients who suffered no HBV reactivation. Initially, we found a significant difference of HCV carriage (P",
keywords = "Co-infection, HBV, HCV, Reactivation, Renal transplantation",
author = "Yen, {Tzung Hai} and Huang, {Chiu Ching} and Lin, {Hsin Hung} and Huang, {Jeng Yi} and Tian, {Ya Chun} and Yang, {Chih Wei} and Wu, {Mai Szu} and Fang, {Ji Tseng} and Yu, {Chun Chen} and Chiang, {Yang Jen} and Chu, {Sheng Hsieh}",
year = "2006",
month = "4",
doi = "10.1093/ndt/gfk023",
language = "English",
volume = "21",
pages = "1046--1052",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?

AU - Yen, Tzung Hai

AU - Huang, Chiu Ching

AU - Lin, Hsin Hung

AU - Huang, Jeng Yi

AU - Tian, Ya Chun

AU - Yang, Chih Wei

AU - Wu, Mai Szu

AU - Fang, Ji Tseng

AU - Yu, Chun Chen

AU - Chiang, Yang Jen

AU - Chu, Sheng Hsieh

PY - 2006/4

Y1 - 2006/4

N2 - Background. Hepatitis B virus (HBV) is endemic in Taiwan. Transplantation followed by long-term immunosuppressive medications may precipitate HBV reactivation. Interference of hepatitis C virus (HCV) with HBV gene expression and replication has been confirmed in many studies involving non-transplant populations. This study investigates the incidence of HBV reactivation following renal transplantation and compares the clinical outcome, especially the liver outcome, of patients with or without HCV co-infection. Methods. Fifty-one of 512 renal transplant recipients were positive for hepatitis B surface antigen before surgery, and were followed for 81.6±7.5 (4-120) months. Seventeen of 51 patients acquired HCV before transplantation and six patients acquired HCV after renal transplantation. Results. At the end of this assessment, we had 28 patients who suffered HBV reactivation and another 23 patients who suffered no HBV reactivation. Initially, we found a significant difference of HCV carriage (P

AB - Background. Hepatitis B virus (HBV) is endemic in Taiwan. Transplantation followed by long-term immunosuppressive medications may precipitate HBV reactivation. Interference of hepatitis C virus (HCV) with HBV gene expression and replication has been confirmed in many studies involving non-transplant populations. This study investigates the incidence of HBV reactivation following renal transplantation and compares the clinical outcome, especially the liver outcome, of patients with or without HCV co-infection. Methods. Fifty-one of 512 renal transplant recipients were positive for hepatitis B surface antigen before surgery, and were followed for 81.6±7.5 (4-120) months. Seventeen of 51 patients acquired HCV before transplantation and six patients acquired HCV after renal transplantation. Results. At the end of this assessment, we had 28 patients who suffered HBV reactivation and another 23 patients who suffered no HBV reactivation. Initially, we found a significant difference of HCV carriage (P

KW - Co-infection

KW - HBV

KW - HCV

KW - Reactivation

KW - Renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=33645293435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645293435&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfk023

DO - 10.1093/ndt/gfk023

M3 - Article

C2 - 16390851

AN - SCOPUS:33645293435

VL - 21

SP - 1046

EP - 1052

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 4

ER -